BPCE
Bank Pictet & Cie (Europe) Portfolio holdings
AUM
$4.68B
1-Year Return
16.47%
This Quarter Return
+6.88%
1 Year Return
+16.47%
3 Year Return
+101.24%
5 Year Return
+155.05%
10 Year Return
+381.72%
AUM
$4.09B
AUM Growth
+$263M
(+6.9%)
Cap. Flow
+$61.2M
Cap. Flow
% of AUM
1.49%
Top 10 Holdings %
Top 10 Hldgs %
49.39%
Holding
180
New
12
Increased
57
Reduced
53
Closed
26
Top Buys
| 1 |
D.R. Horton
DHI
|
+$37.6M |
| 2 |
O'Reilly Automotive
ORLY
|
+$32M |
| 3 |
Microsoft
MSFT
|
+$26M |
| 4 |
NVIDIA
NVDA
|
+$23.6M |
| 5 |
UnitedHealth
UNH
|
+$18M |
Top Sells
| 1 |
Range Resources
RRC
|
+$28.9M |
| 2 |
Medtronic
MDT
|
+$28.4M |
| 3 |
Danaher
DHR
|
+$26.6M |
| 4 |
Nike
NKE
|
+$22.7M |
| 5 |
International Flavors & Fragrances
IFF
|
+$17.1M |
Sector Composition
| 1 | Technology | 24.96% |
| 2 | Healthcare | 18.61% |
| 3 | Consumer Discretionary | 14.99% |
| 4 | Communication Services | 13.42% |
| 5 | Financials | 11.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Tandem Diabetes Care
TNDM
$829M
| $420K | 0.01% |
10,416
-5,498
| -35% | -$222K |
|
127
Zebra Technologies
ZBRA
$15.9B
| $388K | 0.01% |
1,257
-849
| -40% | -$262K |
|
128
Sarepta Therapeutics
SRPT
$1.82B
| $350K | 0.01% |
+2,214
| New | +$350K |
|
129
Vertex Pharmaceuticals
VRTX
$101B
| $348K | 0.01% |
742
-296
| -29% | -$139K |
|
130
Iovance Biotherapeutics
IOVA
$821M
| $345K | 0.01% |
42,973
-10,917
| -20% | -$87.6K |
|
131
Tenet Healthcare
THC
$17B
| $327K | 0.01% |
2,458
-2,069
| -46% | -$275K |
|
132
Arista Networks
ANET
$175B
| $316K | 0.01% |
+3,612
| New | +$316K |
|
133
Corteva
CTVA
$50.5B
| $309K | 0.01% |
5,731
+66
| +1% | +$3.56K |
|
134
Health Care Select Sector SPDR Fund
XLV
$34.2B
| $296K | 0.01% |
2,030
| – | – |
|
135
Apollo Global Management
APO
$79B
| $295K | 0.01% |
2,500
| – | – |
|
136
Align Technology
ALGN
$9.54B
| $294K | 0.01% |
+1,218
| New | +$294K |
|
137
Vaxcyte
PCVX
$4.18B
| $294K | 0.01% |
3,894
-952
| -20% | -$71.9K |
|
138
ServiceNow
NOW
$193B
| $291K | 0.01% |
370
| – | – |
|
139
Pfizer
PFE
$136B
| $283K | 0.01% |
10,100
-13,100
| -56% | -$367K |
|
140
iRhythm Technologies
IRTC
$5.78B
| $273K | 0.01% |
2,538
-643
| -20% | -$69.2K |
|
141
Repligen
RGEN
$6.39B
| $270K | 0.01% |
2,144
+664
| +45% | +$83.7K |
|
142
Blackstone
BX
$142B
| $260K | 0.01% |
2,100
| – | – |
|
143
UBS Group
UBS
$129B
| $256K | 0.01% |
8,709
| – | – |
|
144
CRH
CRH
$76.1B
| $254K | 0.01% |
3,383
-47,738
| -93% | -$3.58M |
|
145
iShares MSCI Japan ETF
EWJ
$15.7B
| $235K | 0.01% |
3,440
| – | – |
|
146
Prudential Financial
PRU
$37.6B
| $234K | 0.01% |
2,000
| – | – |
|
147
PayPal
PYPL
$63.9B
| $231K | 0.01% |
3,985
-3,691
| -48% | -$214K |
|
148
iShares Core S&P Small-Cap ETF
IJR
$85.7B
| $225K | 0.01% |
2,110
| – | – |
|
149
SPDR S&P MidCap 400 ETF Trust
MDY
$24B
| $214K | 0.01% |
400
| – | – |
|
150
Zimmer Biomet
ZBH
$20.4B
| $203K | ﹤0.01% |
1,869
| – | – |
|